# APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat

> **NCT00100126** · PHASE3 · COMPLETED · sponsor: **Advancis Pharmaceutical Corporation** · enrollment: 500 (—)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** Amoxicillin Pulsatile Release Multiparticluate Sprinkle

## Key facts

- **NCT ID:** NCT00100126
- **Lead sponsor:** Advancis Pharmaceutical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 500 (—)
- **Last updated:** 2006-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00100126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00100126, "APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00100126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*